We initiate coverage on STI with a BUY recommendation based on a target price of Bt10.10, implying an upside of 29% from the current price. We derive our target price from a sum-of-the-parts approach and apply a 15% small-cap discount.
Investment thesis:
Risks: Reliance on limited industries, delay in project completion, shortage of experienced personnel, and adverse regulatory changes.